Stomach rebuilding surgeries and blood sugar in gastric cancer with diabetes
Compares stomach rebuilding surgeries in people with gastric cancer and diabetes.
Key facts
- Who runs it
- Korea University Anam Hospital
- Where
- Seoul, South KoreaSee the site
- Trial code
- Registry title
- Surgical TreAtment for Obesity Related Disease and Onco-Metabolic Surgery
- Status
- Recruiting
- People taking part
- 120 people, planned
- Started
- 1 Dec 2020
- Expected to end
- Dec 2027
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Long limb Roux-en-Y reconstruction after subtotal gastrectomy
- Conventional Roux-en-Y reconstruction after subtotal gastrectomy
- Billroth II reconstruction after subtotal gastrectomy
- Record updated
- 7 August 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with early-stage stomach cancer in the lower part of the stomach who also have type 2 diabetes and a higher body weight. It compares three ways of reconnecting the gut after stomach surgery.
- Age
- 20 to 69 years
- Sex
- All sexes can join.
- Disease stage
- Adenocarcinoma of the lower (distal) stomach confirmed by biopsy, clinical stage I-II. Type 2 diabetes with HbA1c ≥ 6.5% (48 mmol/mol).
- Earlier treatment
- People using insulin to control blood sugar at screening cannot join. People who had earlier stomach or bowel, spleen, liver, bile duct or pancreas surgery cannot join, apart from hemorrhoid, hernia and appendix operations.
- Biomarker or test result
- HbA1c ≥ 6.5% (48 mmol/mol) and body mass index ≥ 23 kg/m2.
Main reasons for not taking part
- Using insulin for blood sugar control at screening
- Earlier gastrointestinal surgery (except hemorrhoid, hernia, appendix operations)
- Serious heart, kidney, liver or lung disease
- Another cancer within 5 years (some skin cancers excepted)
- Frail elderly (Rockwood Clinical Frailty Scale ≥5) or pregnancy
The registry criteria, word for word
Show all 20 criteriaShow less
Who can take part
- Distal gastric adenocarcinoma diagnosed pathologically under preoperative endoscopic biopsy, and clinical stage I-II
- Body mass index ≥ 23 kg/m2
- Type 2 diabetes and HbA1c ≥ 6.5%
Who cannot take part
- Prior gastrointestinal surgery including splenectomy, hepatobiliary and pancreatic surgery (except hemorrhoidectomy, herniorrhaphy, and appendectomy)
- Abdominal, thoracic, pelvic and/or obstetric-gynecologic surgery within 3 months
- Cardiovascular conditions including significant known CAD, uncompensated congestive heart failure, history of stroke, or uncontrolled hypertension. Subjects with CAD that have been successfully treated with CABG or PCI, and have no evidence of active ischemia are eligible
- Use of investigational therapy or participation in any other clinical trial within 3 months
- Kidney disease including renovascular hypertension, renal artery stenosis, or end-stage renal disease
- Chronic liver disease including liver cirrhosis, alpha-1 antitrypsin deficiency
- Gastrointestinal disorders including inflammatory bowel disease (Crohn's disease or ulcerative colitis) or any malabsorptive disorders
- Psychiatric disorders including dementia, active psychosis, history of suicide attempts, alcohol or drug abuse within 12 months
- Severe pulmonary disease defined as FEV1 <50% of predicted value
- Malignancy within 5 years (except squamous cell and basal cell cancer of the skin). Subjects diagnosed with early or stage I cancer than have been successfully treated are eligible per investigator discretion
- Any condition or major illness that, in the investigator's judgement, places the subject at undue risk by participating in the study
- Anemia defined as hemoglobin less than 8 in females and 10 in males
- Insulin usage for glycemic control at the time of screening evaluation
- Frail elderly (Rockwood Clinical Frailty Scale ≥5)
- Unable to understand the risks, realistic benefits and compliance requirements of each program
- Geographic inaccessibility
- Pregnancy
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 69 years old?
Where in South Korea
- Korea University Anam HospitalSeoul, South KoreaContact: Sungsoo Park, MD, PhDTaking people
About the trial
What the trial wants to find out
This is a prospective, multi-center, randomized controlled trial to compare Billroth II reconstruction versus conventional Roux-en-Y reconstruction versus long limb Roux-en-Y reconstruction for glycemic control in patients with concurrent type 2 diabetes and gastric cancer.
The 3 groups in the trial
- Long limb Roux-en-Y reconstructionExisting treatment, for comparison
Long limb Roux-en-Y reconstruction method follows subtotal gastrectomy for gastric cancer.
Treatment: Long limb Roux-en-Y reconstruction after subtotal gastrectomy
- Conventional Roux-en-Y reconstructionExisting treatment, for comparison
Conventional Roux-en-Y reconstruction method follows subtotal gastrectomy for gastric cancer.
Treatment: Conventional Roux-en-Y reconstruction after subtotal gastrectomy
- Billroth II reconstructionExisting treatment, for comparison
Billroth II reconstruction method follows subtotal gastrectomy for gastric cancer
Treatment: Billroth II reconstruction after subtotal gastrectomy
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Controlled Trial Comparing Billroth II Reconstruction Versus Conventional Roux-en-Y Reconstruction Versus Long Limb Roux-en-Y Reconstruction for Glycemic Control in Patients With Concurrent Type 2 Diabetes and Gastric Cancer
- Plain-language title
- Stomach rebuilding surgeries and blood sugar in gastric cancer with diabetesGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 12 November 2026.
- Fit questions
- Built from NCT04284943, who can take part
- Record updated
- 7 August 2026